tiprankstipranks
Trending News
More News >
China Regenerative Medicine International Limited (HK:8158)
:8158
Hong Kong Market
Advertisement

China Regenerative Medicine International Limited (8158) Income Statement

Compare
0 Followers

China Regenerative Medicine International Limited Income Statement

Last quarter (Q4 2024), China Regenerative Medicine International Limited's total revenue was HK$15.42M, a decrease of -136.21% from the same quarter last year. In Q4, China Regenerative Medicine International Limited's net income was HK$462.00K. See China Regenerative Medicine International Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
HK$ 90.62MHK$ 69.49MHK$ 41.54MHK$ 282.90MHK$ 182.14M
Gross Profit
HK$ 57.65MHK$ 19.42MHK$ 37.62MHK$ 67.73MHK$ 41.81M
Operating Expenses
HK$ 38.77MHK$ 126.14MHK$ 25.33MHK$ 6.01MHK$ 181.01M
Depreciation and Amortization
HK$ 574.00KHK$ 11.32MHK$ 5.39MHK$ 78.00KHK$ 1.73M
EBITDA
HK$ 29.84MHK$ -95.40MHK$ 14.44MHK$ 64.66MHK$ -121.84M
Operating Income
HK$ 18.88MHK$ -106.72MHK$ 12.29MHK$ 64.59MHK$ -37.53M
Other Income/Expenses
HK$ 11.62MHK$ -979.00KHK$ -3.54MHK$ 2.66MHK$ -104.57M
Pretax Income
HK$ 17.75MHK$ -107.70MHK$ 8.27MHK$ 64.29MHK$ -142.10M
Net Income
HK$ 17.75MHK$ -107.70MHK$ 4.55MHK$ 51.83MHK$ -404.23M
Per Share Metrics
Basic EPS
HK$ 0.06HK$ -0.38HK$ 0.02HK$ 0.18HK$ -1.80
Diluted EPS
HK$ 0.06HK$ -0.38HK$ 0.02HK$ 0.10HK$ -1.80
Weighted Average Shares Outstanding
304.49M 286.41M 285.43M 285.43M 160.68M
Weighted Average Shares Outstanding (Diluted)
304.25M 286.41M 285.43M 285.43M 160.68M
Currency in HKD

China Regenerative Medicine International Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis